Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tolerability of high-dose ceftriaxone in CNS infections: a prospective multicentre cohort study.
Le Turnier P, Navas D, Garot D, Guimard T, Bernard L, Tattevin P, Vandamme YM, Hoff J, Chiffoleau A, Dary M, Leclair-Visonneau L, Grégoire M, Pere M, Boutoille D, Sébille V, Dailly E, Asseray N; High-Dose Ceftriaxone CNS Infections Study Group. Le Turnier P, et al. Among authors: asseray n. J Antimicrob Chemother. 2019 Apr 1;74(4):1078-1085. doi: 10.1093/jac/dky553. J Antimicrob Chemother. 2019. PMID: 30698733 Clinical Trial.
High-Dosage Cefazolin Achieves Sufficient Cerebrospinal Diffusion To Treat an External Ventricular Drainage-Related Staphylococcus aureus Ventriculitis.
Grégoire M, Gaborit B, Deschanvres C, Lecomte R, Deslandes G, Dailly É, Ambrosi X, Bellouard R, Asseray N, Lakhal K, Boutoille D. Grégoire M, et al. Among authors: asseray n. Antimicrob Agents Chemother. 2019 Jan 29;63(2):e01844-18. doi: 10.1128/AAC.01844-18. Print 2019 Feb. Antimicrob Agents Chemother. 2019. PMID: 30420481 Free PMC article.
High-Dose Ceftriaxone for Bacterial Meningitis and Optimization of Administration Scheme Based on Nomogram.
Grégoire M, Dailly E, Le Turnier P, Garot D, Guimard T, Bernard L, Tattevin P, Vandamme YM, Hoff J, Lemaitre F, Verdier MC, Deslandes G, Bellouard R, Sébille V, Chiffoleau A, Boutoille D, Navas D, Asseray N. Grégoire M, et al. Among authors: asseray n. Antimicrob Agents Chemother. 2019 Aug 23;63(9):e00634-19. doi: 10.1128/AAC.00634-19. Print 2019 Sep. Antimicrob Agents Chemother. 2019. PMID: 31235630 Free PMC article. Clinical Trial.
Development and validation of a dosing nomogram for amoxicillin in infective endocarditis.
Rambaud A, Gaborit BJ, Deschanvres C, Le Turnier P, Lecomte R, Asseray-Madani N, Leroy AG, Deslandes G, Dailly É, Jolliet P, Boutoille D, Bellouard R, Gregoire M; Nantes Anti-Microbial Agents PK/PD (NAMAP) study group. Rambaud A, et al. J Antimicrob Chemother. 2020 Oct 1;75(10):2941-2950. doi: 10.1093/jac/dkaa232. J Antimicrob Chemother. 2020. PMID: 32601687
Gram-negative prosthetic joint infections managed according to a multidisciplinary standardized approach: risk factors for failure and outcome with and without fluoroquinolones.
Grossi O, Asseray N, Bourigault C, Corvec S, Valette M, Navas D, Happi-Djeukou L, Touchais S, Bémer P, Boutoille D; Nantes Bone and Joint Infections Study Group. Grossi O, et al. Among authors: asseray n. J Antimicrob Chemother. 2016 Sep;71(9):2593-7. doi: 10.1093/jac/dkw202. Epub 2016 Jun 7. J Antimicrob Chemother. 2016. PMID: 27278900
76 results